Clinical, biochemical and liver tissue changes in Hepatitis-B Gray zone patients and determine eligibility for treatment thereof.
Not Applicable
- Conditions
- Health Condition 1: B181- Chronic viral hepatitis B withoutdelta-agent
- Registration Number
- CTRI/2023/12/060743
- Lead Sponsor
- I.P.G.M.R, Kolkata
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Hepatitis B patients
1. Age > 18 years
2. Fulfilling Gray zone criteria
a) Grey zone A (GZ- A): HBeAg positive, normal ALT levels and serum HBV DNA <106 IU/ml;
b) Grey zone B (GZ- B): HBeAg positive, elevated ALT levels and serum HBV DNA <2 × 104 IU/ml;
c) Grey zone C (GZ- C): HBeAg negative, normal ALT levels and serum HBV DNA <2 × 10 3 IU/ml;
d) Grey zone D (GZ- D): HBeAg negative, elevated ALT levels and serum HBV DNA >2 × 10 3 IU/ml.
Exclusion Criteria
1. subjects unwilling to give consent
2. subjects on treatment or features of Cirrhosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method